Barbara L. Weber

Nature · 2002–2012

A researcher in the Science corpus: 11 papers; trusts 0 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Who trusts Barbara L. Weber

1. Alan Ashworth (in Genetics)

Papers from Barbara L. Weber's perspective

Ordered by how strongly the researchers Barbara L. Weber trusts endorse each paper. Same corpus, a different order for every researcher.

1. Cancer Incidence in BRCA1 mutation carriers. (Journal of the National Cancer Institute)
2. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. (Proceedings of the National Academy of Sciences of the United States of America)
3. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. (American Journal of Human Genetics)
4. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
5. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. (New England Journal of Medicine)
6. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. (Journal of the National Cancer Institute)
7. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. (Journal of the National Cancer Institute)
8. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status (Nature)
9. Blocking oncogenic Ras signaling for cancer therapy. (Journal of the National Cancer Institute)
10. Large-scale analysis of the human and mouse transcriptomes (Proceedings of the National Academy of Sciences of the United States of America)

Their papers

• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity (2012) — 7,455 citations
• Network modeling links breast cancer susceptibility and centrosome dysfunction. (2007) — 637 citations
• Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations (2002) — 980 citations
• COT/MAP3K8 drives resistance to RAF inhibition through MAP kinase pathway reactivation (2010) — 731 citations
• microRNAs exhibit high frequency genomic alterations in human cancer. (2006) — 1,119 citations
• Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. (2004) — 1,067 citations
• Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. (2004) — 644 citations
• Breast and ovarian cancer. (2003) — 658 citations
• Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. (2002) — 764 citations
• BRAF and RAS mutations in human lung cancer and melanoma. (2002) — 1,126 citations
• Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. (2002) — 1,495 citations